Operating Margin: Operating margin measurement of what proportion of a company's revenue is left over after paying for variable costs of production such as wages, raw materials, etc. Calculated as: Operating Income / Total Revenues
Xenetic Biosciences, Inc. (XBIO) had Operating Margin of -147.09% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.66M |
|
$-0.93M |
|
-- |
|
$0.66M |
|
$1.63M |
|
$-0.97M |
|
$0.04M |
|
$-0.93M |
|
$-0.93M |
|
$-0.93M |
|
$-0.93M |
|
$-0.93M |
|
$-0.93M |
|
$-0.97M |
|
$-0.97M |
|
2.29M |
|
2.29M |
|
$-0.41 |
|
$-0.41 |
|
| Balance Sheet Financials | |
$6.65M |
|
-- |
|
$0.31M |
|
$6.97M |
|
$0.90M |
|
-- |
|
-- |
|
$0.90M |
|
$6.07M |
|
$6.07M |
|
$6.07M |
|
2.34M |
|
| Cash Flow Statement Financials | |
$-1.41M |
|
-- |
|
-- |
|
$7.88M |
|
$6.47M |
|
$-1.41M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
|
Operating Margin |
-147.09% |
-147.09% |
|
-- |
|
-140.73% |
|
-140.73% |
|
$-1.41M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
-- |
|
-- |
|
-15.31% |
|
-15.31% |
|
-13.34% |
|
-15.31% |
|
$2.59 |
|
$-0.62 |
|
$-0.62 |
|